Cargando…

Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19

Detalles Bibliográficos
Autores principales: Caceres, Jennifer, Maki, Dennis G., Hennekens, Charles H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928701/
https://www.ncbi.nlm.nih.gov/pubmed/35307362
http://dx.doi.org/10.1016/j.amjmed.2022.02.041
_version_ 1784670696410972160
author Caceres, Jennifer
Maki, Dennis G.
Hennekens, Charles H.
author_facet Caceres, Jennifer
Maki, Dennis G.
Hennekens, Charles H.
author_sort Caceres, Jennifer
collection PubMed
description
format Online
Article
Text
id pubmed-8928701
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89287012022-03-17 Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19 Caceres, Jennifer Maki, Dennis G. Hennekens, Charles H. Am J Med Commentary Elsevier Inc. 2022-07 2022-03-17 /pmc/articles/PMC8928701/ /pubmed/35307362 http://dx.doi.org/10.1016/j.amjmed.2022.02.041 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Caceres, Jennifer
Maki, Dennis G.
Hennekens, Charles H.
Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19
title Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19
title_full Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19
title_fullStr Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19
title_full_unstemmed Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19
title_short Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19
title_sort cautious optimism and considerations for health providers and patients: oral antiviral for early treatment of high-risk patients and vaccines for prevention of covid-19
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928701/
https://www.ncbi.nlm.nih.gov/pubmed/35307362
http://dx.doi.org/10.1016/j.amjmed.2022.02.041
work_keys_str_mv AT caceresjennifer cautiousoptimismandconsiderationsforhealthprovidersandpatientsoralantiviralforearlytreatmentofhighriskpatientsandvaccinesforpreventionofcovid19
AT makidennisg cautiousoptimismandconsiderationsforhealthprovidersandpatientsoralantiviralforearlytreatmentofhighriskpatientsandvaccinesforpreventionofcovid19
AT hennekenscharlesh cautiousoptimismandconsiderationsforhealthprovidersandpatientsoralantiviralforearlytreatmentofhighriskpatientsandvaccinesforpreventionofcovid19